200 related articles for article (PubMed ID: 18191201)
41. Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis.
Schetelig J; van Biezen A; Brand R; Caballero D; Martino R; Itala M; García-Marco JA; Volin L; Schmitz N; Schwerdtfeger R; Ganser A; Onida F; Mohr B; Stilgenbauer S; Bornhäuser M; de Witte T; Dreger P
J Clin Oncol; 2008 Nov; 26(31):5094-100. PubMed ID: 18711173
[TBL] [Abstract][Full Text] [Related]
42. Etiology and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia.
Cheson BD
Clin Adv Hematol Oncol; 2009 Apr; 7(4):263-71. PubMed ID: 19521331
[TBL] [Abstract][Full Text] [Related]
43. Optimal management of older patients with chronic lymphocytic leukemia: some facts and principles guiding therapeutic choices.
Tadmor T; Polliack A
Blood Rev; 2012 Jan; 26(1):15-23. PubMed ID: 21955980
[TBL] [Abstract][Full Text] [Related]
44. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
[TBL] [Abstract][Full Text] [Related]
45. A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia.
Loeder S; Zenz T; Schnaiter A; Mertens D; Winkler D; Döhner H; Debatin KM; Stilgenbauer S; Fulda S
Cancer Res; 2009 Dec; 69(23):8977-86. PubMed ID: 19920200
[TBL] [Abstract][Full Text] [Related]
46. New trends in CLL treatment.
Travade P; Chastang C; Dighiero G; Binet JL
Blood Cells; 1987; 12(2):485-502. PubMed ID: 3304473
[TBL] [Abstract][Full Text] [Related]
47. Updates in CLL: prognostic markers and their implication for treatment strategies.
Clin Adv Hematol Oncol; 2007 Apr; 5(4 Suppl 7):4-14; quiz 15-6. PubMed ID: 17637593
[No Abstract] [Full Text] [Related]
48. The role of minimal residual disease measurements in the therapy for CLL: is it ready for prime time?
Böttcher S; Hallek M; Ritgen M; Kneba M
Hematol Oncol Clin North Am; 2013 Apr; 27(2):267-88. PubMed ID: 23561473
[TBL] [Abstract][Full Text] [Related]
49. Evolution of treatment strategies in chronic lymphocytic leukemia. Part 2 of a 3-Part series: Advances in the treatment of hematologic malignancies.
Keating MJ; Rai KR; Wierda WG
Clin Adv Hematol Oncol; 2005 Aug; 3(8):1-10; quiz 11-2. PubMed ID: 16201050
[TBL] [Abstract][Full Text] [Related]
50. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
[TBL] [Abstract][Full Text] [Related]
51. Chronic leukaemias: can they be cured? Part II: Chronic lymphocytic leukaemia.
Mughal TI; Goldman JM
Br J Clin Pract; 1989 Oct; 43(10):353-6. PubMed ID: 2698240
[TBL] [Abstract][Full Text] [Related]
52. Chronic lymphocytic leukaemia: current first-line therapy.
Carney DA; Mulligan SP
Intern Med J; 2009 Jan; 39(1):44-8. PubMed ID: 19290981
[TBL] [Abstract][Full Text] [Related]
53. Chronic lymphocytic leukemia: a clinical review.
Nabhan C; Rosen ST
JAMA; 2014 Dec; 312(21):2265-76. PubMed ID: 25461996
[TBL] [Abstract][Full Text] [Related]
54. Chronic lymphocytic leukaemia--the haematologic basis for diagnosis and treatment.
Jacobs P; Wood L
Hematology; 2002 Feb; 7(1):33-41. PubMed ID: 12171775
[TBL] [Abstract][Full Text] [Related]
55. Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia.
Kharfan-Dabaja MA; Chavez JC; Khorfan KA; Pinilla-Ibarz J
Cancer; 2008 Sep; 113(5):897-906. PubMed ID: 18618518
[TBL] [Abstract][Full Text] [Related]
56. Chronic lymphocytic leukemia . Clinical oral poster session.
Keating MJ
Hematol Cell Ther; 2000 Jun; 42(1):35-9. PubMed ID: 11036949
[No Abstract] [Full Text] [Related]
57. [Chronic lymphatic leukemia. Current status and perspectives].
Hiddemann W
Internist (Berl); 1993 Jun; 34(6):534-41. PubMed ID: 8335443
[No Abstract] [Full Text] [Related]
58. Guidelines on the diagnosis and management of chronic lymphocytic leukaemia.
Oscier D; Fegan C; Hillmen P; Illidge T; Johnson S; Maguire P; Matutes E; Milligan D;
Br J Haematol; 2004 May; 125(3):294-317. PubMed ID: 15086411
[No Abstract] [Full Text] [Related]
59. Revision of the guidelines for diagnosis and therapy of chronic lymphocytic leukemia (CLL).
Eichhorst B; Hallek M
Best Pract Res Clin Haematol; 2007 Sep; 20(3):469-77. PubMed ID: 17707834
[TBL] [Abstract][Full Text] [Related]
60. Nursing guidelines for managing infections in patients with chronic lymphocytic leukemia.
Moran M; Browning M; Buckby E
Clin J Oncol Nurs; 2007 Dec; 11(6):914-24. PubMed ID: 18063549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
